Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baiping Chen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|June 16, 2023
Genomic medicines: the coming waves?Wen Xie, Baiping Chen, John Wong
Nature Reviews. Drug Discovery|October 5, 2021
Publisher Correction: Evolution of the market for mRNA technologyWen Xie, Baiping Chen, John Wong
Nature Reviews. Drug Discovery|September 3, 2021
Evolution of the market for mRNA technologyWen Xie, Baiping Chen, John Wong
Thrombosis Research|August 8, 2002
Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese populationYanhui Lu, Yanfen Zhao, Guozhang Liu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|June 16, 2023
Genomic medicines: the coming waves?Wen Xie, Baiping Chen, John Wong
Nature Reviews. Drug Discovery|October 5, 2021
Publisher Correction: Evolution of the market for mRNA technologyWen Xie, Baiping Chen, John Wong
Nature Reviews. Drug Discovery|September 3, 2021
Evolution of the market for mRNA technologyWen Xie, Baiping Chen, John Wong
Thrombosis Research|August 8, 2002
Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese populationYanhui Lu, Yanfen Zhao, Guozhang Liu, et al.
Pageof 1